MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0002569
Pinnacle Life Science Private Limited - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹314.76 Cr
▲ 10% YoY
Net profit · FY 2024
₹33.56 Cr
Net margin 10.7%
EBITDA · FY 2024
₹51.54 Cr
EBITDA margin 16.4%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹7.86 Cr
Issued & subscribed
Open charges
₹386.56 Cr
Satisfied ₹58.24 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
777
Provident fund records
About Pinnacle Life Science Private Limited
Data last updated:
Pinnacle Life Science Private Limited is a private limited company based in Baddi, Himachal Pradesh, India, a subsidiary of Aarti Drugs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24232HP2003PTC030912. Its GSTIN is 02AAICS2528Q1Z2 (Himachal Pradesh). The company holds 11 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.86 Cr. It was formerly known as Siesta Formulation Private Limited. It is led by directors including Vishwa Harshit Savla (Managing Director) and Parth Samir Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Near Telephone Exchange Manpura, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2024, the company reported a revenue of ₹314.76 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹33.56 Cr (net margin 10.7%) and EBITDA of ₹51.54 Cr (EBITDA margin 16.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 16% over five years.
The company has about 777 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pinnacle Life Science. As per MCA filings, the company has open charges of ₹386.56 Cr and satisfied charges of ₹58.24 Cr on record. Court records list 17 cases involving the company, including 13 filed by the company and 4 filed against it; 6 cases are pending. The company has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.72 Cr; the latest was in February 2025. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Globela Pharma Private Limited with revenue of ₹295.59 Cr.
Pinnacle Life Science Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002569). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pinnaclelifescience.com.
Company details
CIN U24232HP2003PTC030912
Registration Number 030912
Incorporation Date 15 January 2003
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Aarti Drugs Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0002569
CIN history
Pinnacle Life Science has one previous CIN (Corporate Identification Number): U24232MP2003PTC015507. The current CIN is U24232HP2003PTC030912, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232HP2003PTC030912 | Current |
| U24232MP2003PTC015507 | Previous |
Key People
Vishwa Harshit Savla Managing Director Parth Samir Shah Whole-Time Director Harshit Manilal Savla Director Recognitions & Rankings of Pinnacle Life Science
Contact details
Pinnacle Life Science Private Limited's registered office is in Baddi, Himachal Pradesh. Its website is pinnaclelifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNear Telephone Exchange Manpura, Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pinnacle Life Science Private Limited, buy the company report.
Comprehensive company report
Pinnacle Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pinnacle Life Science operates one associated brand: Pinnacle Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and CDMO services focused on oncology and other therapeutic areas. | pinnaclelifescience.com |
Business activity
The main business activity of Pinnacle Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pinnacle Life Science Private Limited, buy the company report.
Financials of Pinnacle Life Science Private Limited
FY 2025 filings availablePinnacle Life Science Private Limited reported revenue of ₹314.76 Cr (up 10% YoY) for FY 2024.
Revenue · FY 2024
₹314.76 Cr ▲ 10%
Net profit · FY 2024
₹33.56 Cr margin 10.7%
EBITDA · FY 2024
₹51.54 Cr margin 16.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 3%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▲ 12%
5 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 10% growth in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹314.76 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.56 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.4% | ||||
| Net Profit Margin | 10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pinnacle Life Science Private Limited, buy the company report.
Board of directors of Pinnacle Life Science Private Limited
Pinnacle Life Science has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshit Manilal Savla Also directs: Harshit Ventures Limited Liability Partnership, Aarti Life Science LLP, Aarti Drugs Limited and 5 more | Director | 14 Nov 2014 | 11 Years 11 Months | Current |
| Harit Pragji Shah Also directs: Harshit Ventures Limited Liability Partnership, Aarti Life Science LLP, Aarti Drugs Limited and 5 more | Director | 14 Nov 2014 | 11 Years 11 Months | Current |
| Neha Rajen Gada | Director | 01 Jul 2024 | 2 Years 3 Months | Current |
| Parth Samir Shah Also directs: Spe Process Pumps Private Limited | Whole-Time Director | 19 Jul 2023 | 3 Years 3 Months | Current |
| Vishwa Harshit Savla | Managing Director | 08 Sep 2014 | 12 Years 1 Months | Current |
| Adhish Prakash Patil Also directs: Aarti Life Science LLP, Aarti Speciality Chemicals Limited, Salco Extrusions Private Limited and 1 more | Director | 14 Nov 2014 | 11 Years 11 Months | Current |
Peer comparison
Pinnacle Life Science Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pinnacle Life Science Private Limitedthis company | ₹314.76 Cr (FY 2024) | ₹33.56 Cr | 10.7% | 10.0% | 777 | Baddi, Himachal Pradesh, India |
| Globela Pharma Private Limited | ₹295.59 Cr (FY 2025) | 13.0% | Surat, Gujarat, India | |||
| Ravenbhel Health Care Private Limited | ₹290.95 Cr (FY 2025) | 16.0% | Jammu, Jammu and Kashmir, India | |||
| Agio Pharmaceuticals Limited | ₹287.95 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Gracure Pharmaceuticals Limited | ₹287.44 Cr (FY 2025) | 27.0% | New Delhi, Delhi, India | |||
| Sava Healthcare Limited | ₹284.97 Cr (FY 2025) | 14.0% | Wadhwan, Gujarat, India | |||
| Med Manor Organics Private Limited | ₹284.93 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Pinnacle Life Science Private Limited, buy the company report.
Auditor
Pinnacle Life Science Private Limited is audited by GOKHALE & SATHE for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOKHALE & SATHE | FY 2024 | 103264W |
Shareholding
The shareholding of Pinnacle Life Science Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pinnacle Life Science Private Limited, buy the company report.
Charges & borrowings
Open charges
₹386.56 Cr
Satisfied charges
₹58.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2025 | 101070895 | The Hongkong and Shanghai Banking Corporation Limited | ₹40 Cr | Open | |
| 19 May 2023 | 100743484 | Axis Bank Limited | ₹10 Cr | Open | |
| 29 Apr 2022 | 100572698 | Axis Bank Limited | ₹33 Cr | Open | |
| 23 Mar 2022 | 100560490 | The Hongkong and Shanghai Banking Corporation Limited | ₹60 Cr | Open | |
| 04 Mar 2022 | 100552806 | Axis Bank Limited | ₹98 Cr | Open |
To see the full charge records of Pinnacle Life Science Private Limited, buy the company report.
Total charge records: 24 View all charges
Deals & funding
Pinnacle Life Science Private Limited has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.72 Cr; the latest was in February 2025.
Total deals
5
Rights issues
2
Secondary share transfers
2
Funding round
1
Disclosed funding
₹1.72 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2025 | Rights issue | ₹25 Cr | Investors: Aarti Drugs Limited |
| Feb 2015 | Rights issue | ₹6.05 Cr | Investors: Aarti Drugs Limited |
| Apr 2014 | Secondary share transfer | Undisclosed | Buyer: Aarti Drugs Limited & Harshit Salva, Aarti Drugs Limited Seller: 4 individuals |
| Mar 2011 | Funding round | ₹1.72 Cr | Investors: 4 individuals |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pinnacle Life Science Private Limited has 17 court cases on record: 13 filed by Pinnacle Life Science, 4 filed against it. 6 cases are pending and 11 are disposed.
Total cases
17
Filed by the company
13
Filed against the company
4
Pending
6
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 4 | 6 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed by the company against Futurelife Pharmaceuticals Pvt Ltd and Ors and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed by the company against Future Life Pharmaceuticals Pvt Ltd and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS) | Filed by the company against M/S. Nava Healthcare Pvt. Ltd. and 3 Others and 3 others | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Nava Healthcare Pvt. Ltd. and 3 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against M/S Futurelife Pharmaceuticals Pvt. Ltd. and 2 others | Disposed |
To see the full case history of Pinnacle Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Pinnacle Life Science Private Limited was last rated by Crisil on 15 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Oct 2020 |
To see the full credit ratings and regulatory alerts of Pinnacle Life Science Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pinnacle Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pinnacle Life Science Private Limited has a workforce of 777 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
Employee count
777
Active EPFO establishments
1
Employee growth
21.41%
GST
Pinnacle Life Science has 11 GST registrations: 7 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
7
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAICS2528Q1Z2 | Himachal Pradesh | Active | 01 Jul 2017 |
| 05AAICS2528Q1ZW | Uttarakhand | Active | 01 Jul 2017 |
| 09AAICS2528Q1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
| 11AAICS2528Q1Z3 | Sikkim | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pinnacle Life Science Private Limited, buy the company report.
Recent activity
Pinnacle Life Science Private Limited has 20 board changes on record since 2007: 6 appointments and 14 cessations. The latest: Neha Rajen Gada ceased to be Additional Director on 18 Sep 2024.
AGM
Pinnacle Life Science Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Standard Chartered Bank of Rs. 25.00 Cr registered on 20 Jan 2021 with Charge ID 100414612 was modified on 21 Jul 2025.
Filing
Pinnacle Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 40.00 Cr with Charge ID 101070895 was registered on 06 Mar 2025.
Ceased
Neha Rajen Gada ceased to be Additional Director.
Appointed
Neha Rajen Gada was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 33.00 Cr registered on 29 Apr 2022 with Charge ID 100572698 was modified on 21 Mar 2024.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 60.00 Cr registered on 23 Mar 2022 with Charge ID 100560490 was modified on 21 Mar 2024.
Charges
A charge registered on 12 Jun 2017 via Charge ID 100107776 with Others was fully satisfied on 26 Oct 2023.
Charges
A charge registered on 24 Mar 2015 via Charge ID 10559802 with Others was fully satisfied on 26 Oct 2023.
Appointed
Parth Samir Shah was appointed as Whole-Time Director.
Ceased
Parth Samir Shah ceased to be Additional Director.
56 earlier events are in the company report.
Frequently asked questions
Pinnacle Life Science is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 2003 (23+ years old) and is registered under CIN U24232HP2003PTC030912.
Pinnacle Life Science has 6 current directors:
- Vishwa Harshit Savla - Managing Director
- Parth Samir Shah - Whole-Time Director
- Harshit Manilal Savla - Director
- Harit Pragji Shah - Director
- Neha Rajen Gada - Director
- Adhish Prakash Patil - Director
The latest financial statements of Pinnacle Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pinnacle Life Science is 02AAICS2528Q1Z2, registered in Himachal Pradesh. The company has 11 GST registrations in all, of which 7 are active and 4 are cancelled or inactive. Other active GSTINs include 05AAICS2528Q1ZW (Uttarakhand), 09AAICS2528Q1ZO (Uttar Pradesh), 11AAICS2528Q1Z3 (Sikkim).
The CIN (Corporate Identification Number) of Pinnacle Life Science is U24232HP2003PTC030912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pinnacle Life Science has 17 court cases on record: 13 filed by the company and 4 filed against it. 6 are pending. Most are in the district courts.
Pinnacle Life Science was incorporated on 15 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Pinnacle Life Science has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹1.72 Cr; the latest was in February 2025.
The peers of Pinnacle Life Science by revenue are Globela Pharma Private Limited, Ravenbhel Health Care Private Limited, Agio Pharmaceuticals Limited, Gracure Pharmaceuticals Limited, Sava Healthcare Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neha Rajen Gada ceased to be Additional Director on 18 Sep 2024. Neha Rajen Gada was appointed as Director on 01 Jul 2024. Parth Samir Shah was appointed as Whole-Time Director on 19 Jul 2023. Pinnacle Life Science has 20 board changes on record in total.
Yes, Pinnacle Life Science is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0002569).